1 not yet recruiting, 1 unknown. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Not yet recruiting 1 |
Follow Joyce Teng: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical Simvastatin for Treating Infantile Hemangioma 5% simvastatin ointment - Hemangioma Skin | Early Phase 1 | Not yet recruiting | Joyce Teng | 15 | 2026-11-01 | 2026-09-14 |
| Computational Drug Repurposing for All EBS Cases Experimental Group - Epidermolysis Bullosa, Healthy | Unknown | Joyce Teng | 60 | 2017-11-28 | 2024-02-13 |
Epidermolysis Bullosa (1) · Epidermolysis Bullosa Dystrophica (1) · Epidermolysis Bullosa Simplex (1) · Epidermolysis Bullosa, Junctional (1) · Skin Diseases, Genetic (1)
United States (2)
PMID 19267394, PMID 21877134, PMID 23483391, PMID 23651789, PMID 25431026, PMID 25832646, PMID 26194911, PMID 26802230, PMID 27386970, PMID 27940607